ZNF350
Overview
ZNF350 (also known as ZBRK1) encodes a KRAB-domain zinc finger protein that interacts with BRCA1 and functions as a transcriptional repressor. It has been implicated in DNA damage response pathways through its BRCA1 interaction. Recurrent expressed mutations in rhabdomyosarcoma suggest a candidate role in pediatric sarcoma pathogenesis.
Alterations observed in the corpus
- Recurrently expressed mutations (2 cases) in a comprehensive rhabdomyosarcoma (RMS) genomic analysis; interacts with BRCA1; flagged as a candidate target requiring functional validation PMID:24436047
Cancer types (linked)
- RMS: recurrent expressed mutations in pediatric RMS genomic characterization PMID:24436047
Co-occurrence and mutual exclusivity
- Co-listed with TRPC4AP as a recurrently expressed mutation candidate in RMS PMID:24436047
Therapeutic relevance
- BRCA1-interacting partner; loss of ZNF350 function may affect homologous recombination DNA repair, with potential relevance to PARP inhibitor sensitivity (not directly established in this corpus).
Open questions
- Functional role of ZNF350 mutations in RMS is unvalidated; relationship to BRCA1-mediated DNA repair in this tumor type is hypothetical.
Sources
This page was processed by crosslinker on 2026-05-09.